QUOTED. 27 June 2019. Rafael Carbunaru.
New real-world clinical data support Boston Scientific's "all-in-one" spinal cord stimulation device for treating leg and lower-back pain. See what Rafael Carbunaru, VP for R&D in Boston Scientific's neuromodulation division said about it here.
“Each of these two mechanisms appear to be engaged through different primary neural targets in the spinal cord and are optimally activated with different stimulation waveforms and electrical dosing. We designed the Spectra WaveWriter system to optimize how we activate each of these two pathways, not only independently, but also simultaneously.” – Rafael Carbunaru, VP for R&D, Boston Scientific neuromodulation
- Find out more: Real-World Data Support Boston Scientific's Personalized Spinal Cord Stimulation Therapy
Click here for a free trial of Medtech Insight